₹1,200 per dose to ₹225, Serum Institute of India announced a price cut from Rs600 to Rs225 per dose. “The price differential for the holding usable stocks of Covishield shall be compensated in the cost-free doses.
Due process will be informed to all private hospitals very soon," said Serum Institute of India in a statement while announcing the price revision for Covishield.
Bharat Biotech added, “The price differential with any existing stocks of Covaxin in private hospitals shall be compensated in the form of additional doses.
Fresh stocks of Covaxin are available and ready for supplies. Additional production capacity is also available to meet product demand." According to the health ministry, 4.5 million healthcare workers, 7 million frontline workers and 12.7 million people above 60 years of age have received booster doses so far.